-
Supervisory Board member
Dr Nuala Murphy was appointed to the board of Cerba HealthCare in 2023.
Nuala also chairs the Group's CSR Committee. With a background in drug development, Nuala is a strategic advisor to private equity, having held leadership & board roles in the pharmaceutical sector, most recently as President of Drug development and Commercialization at ICON Plc.
Nuala graduated from Trinity College Dublin, was awarded a PhD from the School of Medicine at the University of Leeds, a post-doctorate in neuroscience from the Collège de France, Paris, a diploma in ESG from the Corporate Governance Institute and was certified in corporate governance at INSEAD.